References
- Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral?. ORL J Otorhinolaryngol Relat Spec 2008;70:52–62.
- Miller J, Dengerink H. Control of inner blood flow. Am J Otolaryngol 1988;9:302–16.
- Mattox D, Simmons F. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–70.
- Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65–7.
- Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601–7.
- Rudack C, Langer C, Stoll W, Rust S, Walter M. Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95:454–61.
- Capaccio P, Ottaviani F, Cuccarini V, Ambrosetti U, Fagnani E, Bottero A, Methylenetetrahydrofolate reductase gene mutations as risk factors for sudden hearing loss. Am J Otolaryngol 2005;26:383–7.
- Gross M, Friedman G, Eliashar R, Koren-Morag N, Goldschmidt N, Atta IA, Impact of methionine synthase gene and methylenetetrahydrofolate reductase gene polymorphisms on the risk of sudden sensorineural hearing loss. Audiol Neurootol 2006;11:287–93.
- Quaranta N, Ramunni A, Brescia P, D'Elia A, Vacca A, Ria R. Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss. Otol Neurotol 2008;29:470–4.
- Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001;14(6 Pt 2):44S–54S.
- Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–7.
- Dignat-George F, Sampol L. Circulating endothelial cells in vascular disorders: new insight into an old concept. Eur J Haematol 2000;65:215–20.
- Shantsila E, Watson T, Lip GYH. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007;49:741–52.
- Roberts N, Jahangiri M, Xu Q. Progenitor cells in vascular disease. J Cell Mol Med 2005;9:583–91.
- Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702–12.
- Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422–7.
- Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952–8.
- Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593–600.
- Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981–7.
- Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999–1007.